We are live on !
Find out more
Natixis Portfolio holdings
AUM
$24.8B
Turnover
40.85%
1-Year Est. Return
35.22%
Natixis is a global financial services business line of Groupe BPCE, offering a range of services including corporate and investment banking, asset management, insurance, and wealth management, with a focus on green and sustainable finance.
This Fund
S&P 500
This Quarter Est. Return
+24.29%
1 Year Est. Return
+35.22%
3 Year Est. Return
+126.04%
5 Year Est. Return
+138.3%
10 Year Est. Return
+551.73%
AUM
$24.8B
AUM Growth
-$3.12B
(-11%)
Cap. Flow
-$7.16B
Cap. Flow % of AUM
Cap. Flow %
-28.82%
Top 10 Holdings %
Top 10 Hldgs %
41.04%
Holding
1,405
New
314
Increased
371
Reduced
359
Closed
260
Avg Time Held
Equity + Options
1.5
years
Top 10 Avg Time Held
Equity + Options
1.2
years
Top 20 Avg Time Held
Equity + Options
1.5
years
Avg Time Held Equity only
1.6
years
Top 10 Avg Time Held Equity only
1.3
years
Top 20 Avg Time Held Equity only
1.7
years
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Alphabet (Google) Class A
GOOGL
|
+$267M |
| 2 |
Oracle
ORCL
|
+$219M |
| 3 |
Alphabet (Google) Class C
GOOG
|
+$154M |
| 4 |
Meta Platforms (Facebook)
META
|
+$125M |
| 5 |
Johnson & Johnson
JNJ
|
+$115M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
NVIDIA
NVDA
|
+$1.76B |
| 2 |
Vanguard S&P 500 ETF
VOO
|
+$1.19B |
| 3 |
State Street SPDR Portfolio S&P 500 ETF
SPYM
|
+$738M |
| 4 |
Micron Technology
MU
|
+$535M |
| 5 |
Amazon
AMZN
|
+$456M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Miscellaneous | 36.05% |
| 2 | Technology | 21.93% |
| 3 | Communication Services | 9.47% |
| 4 | Financials | 6.29% |
| 5 | Healthcare | 6.08% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | Held Since | |
|---|---|---|---|---|---|---|---|
951
B&G Foods
BGS
$175M
| $163K | ﹤0.01% |
+41,000
| New | +$190K |
2026 Q2
0 quarters
|
|
952
Kaspi.kz JSC
KSPI
$17.2B
| $159K | ﹤0.01% |
1,838
| – | – |
2024 Q2
8 quarters
|
|
953
Lattice Semiconductor
LSCC
$13.7B
| $159K | ﹤0.01% |
1,037
-157,103
| -99% | -$20.3M |
2025 Q4
2 quarters
|
|
954
Manhattan Associates
MANH
$14.1B
| $156K | ﹤0.01% |
+1,120
| New | +$154K |
2026 Q2
0 quarters
|
|
955
iShares MSCI Taiwan ETF
EWT
$11.4B
| $156K | ﹤0.01% |
+1,435
| New | +$134K |
2026 Q2
0 quarters
|
|
956
Texas Roadhouse
TXRH
$11.3B
| $152K | ﹤0.01% |
785
-22,646
| -97% | -$3.86M |
2025 Q3
3 quarters
|
|
957
GameStop
GME
$12.8B
| $149K | ﹤0.01% |
+6,768
| New | +$155K |
2026 Q2
0 quarters
|
|
958
Clear Secure
YOU
$4.69B
| $149K | ﹤0.01% |
2,678
+757
| +39% | +$41.4K |
2025 Q4
2 quarters
|
|
959
Varonis Systems
VRNS
$5.62B
| $147K | ﹤0.01% |
+3,499
| New | +$103K |
2026 Q2
0 quarters
|
|
960
WisdomTree Japan Hedged Equity Fund
DXJ
$7.87B
| $145K | ﹤0.01% |
2,511
-6,930
| -73% | -$388K |
2026 Q1
1 quarter
|
|
961
TFI International
TFII
$9.45B
| $144K | ﹤0.01% |
1,004
+237
| +31% | +$33.5K |
2024 Q2
8 quarters
|
|
962
Contineum Therapeutics
CTNM
$316M
| $144K | ﹤0.01% |
+9,072
| New | +$119K |
2026 Q2
0 quarters
|
|
963
LGI Homes
LGIH
$994M
| $142K | ﹤0.01% |
+2,225
| New | +$106K |
2026 Q2
0 quarters
|
|
964
Allient
ALNT
$1.47B
| $140K | ﹤0.01% |
+1,359
| New | +$105K |
2026 Q2
0 quarters
|
|
965
First Tracks Biotherapeutics
TRAX
$1.54B
| $138K | ﹤0.01% |
+6,879
| New | +$129K |
2026 Q2
0 quarters
|
|
966
iShares US Basic Materials ETF
IYM
$1.33B
| $136K | ﹤0.01% |
759
+144
| +23% | +$26.4K |
2026 Q1
1 quarter
|
|
967
Axsome Therapeutics
AXSM
$8.18B
| $136K | ﹤0.01% |
555
+254
| +84% | +$55.1K |
2026 Q1
1 quarter
|
|
968
Structure Therapeutics
GPCR
$1.56B
| $135K | ﹤0.01% |
+2,482
| New | +$110K |
2026 Q2
0 quarters
|
|
969
Ambiq Micro
AMBQ
$1.2B
| $132K | ﹤0.01% |
+1,487
| New | +$88.1K |
2026 Q2
0 quarters
|
|
970
CALL
Alliant Energy
LNT
$18.2B
| $130K | ﹤0.01% |
+1,700
| New | +$124K |
2026 Q2
0 quarters
|
|
971
Arrow Electronics
ARW
$10.7B
| $128K | ﹤0.01% |
599
-24,382
| -98% | -$4.87M |
2025 Q4
2 quarters
|
|
972
Telix Pharmaceuticals
TLX
$3.24B
| $127K | ﹤0.01% |
+10,999
| New | +$112K |
2026 Q2
0 quarters
|
|
973
Intuitive Machines
LUNR
$1.69B
| $124K | ﹤0.01% |
5,819
-5,575
| -49% | -$157K |
2024 Q4
6 quarters
|
|
974
Xenon Pharmaceuticals
XENE
$3.53B
| $123K | ﹤0.01% |
+2,037
| New | +$113K |
2026 Q2
0 quarters
|
|
975
FirstService
FSV
$6.43B
| $122K | ﹤0.01% |
856
+133
| +18% | +$18.5K |
2024 Q2
8 quarters
|
|
Similar funds
TWC
Natixis's Q2 2026 Portfolio in Review
As of Q2 2026, Natixis held 1,405 positions worth $24.8B, down 11% from $28B the previous quarter. Its ten largest holdings account for 41% of the portfolio.
Natixis withdrew a net $7.16B in Q2 2026, closing 260 positions and reducing 359 holdings. Its most notable exit was Applied Materials, an estimated $118M position sold in full.
By sector, the portfolio is most concentrated in Miscellaneous at 36% of assets, up from 35% a quarter earlier, followed by Technology and Communication Services.
Against the trend, Natixis opened a new position in Advanced Micro Devices worth $132M.
- Natixis's largest Q2 2026 buy was Advanced Micro Devices: 227,924 shares worth $132M.
- Natixis added most to Alphabet (Google) Class A in Q2 2026, an estimated $267M increase.
- Natixis's biggest Q2 2026 reduction was NVIDIA, cutting an estimated $1.76B.
- Natixis fully exited Applied Materials in Q2 2026, selling an estimated $118M.
- Natixis's ten largest holdings make up 41% of its $24.8B portfolio in Q2 2026.
- Natixis opened 314 new positions and closed 260 in Q2 2026.
- Natixis's portfolio value fell 11% quarter-over-quarter to $24.8B.
Based on Natixis's 13F filing for Q2 2026, filed 13 Aug 2026.